Clinical Trials Browser

Phase 3 × Pulmonary Embolism × Dalteparin × Clear all

NCT05171075 2025-12-19

MAGNOLIA

Phase 3 Active not recruiting

Classical hematologyGastrointestinal

Gastrointestinal Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Phase 3 Completed

300 enrolled 11 charts

Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Phase 3 Completed

1,046 enrolled 24 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT00876915 2015-11-24

PHACS

Phase 3 Terminated

218 enrolled 20 charts

Classical hematology

Pulmonary Embolism, Venous Thromboembolism

NCT00135876 2007-04-27

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Phase 3 Completed

CNSClassical hematology

Brain Neoplasms, Glioma, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism